Device Trial Radar · NCT01501617
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
Last checked: Nov 19, 2026Latest source record: Jan 18, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
56
Actual
Start
Dec 2011
Primary completion
Jun 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- HistogenNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Gleneagles CRC Pte Ltd.
- First posted
- Dec 29, 2011
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 21 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy in relation to dosing in the administration of Hair Stimulating Complex (HSC) in healthy men. HSC will be injected intradermally in the scalps of men with male pattern baldness (i.e. androgenetic alopecia).
Conditions
- Androgenetic Alopecia
Interventions
Hair Stimulating Complex (HSC)Biological
Study preparation (experimental) of 0.8 mL will be injected intradermally at Baseline and Week 6.
Dulbecco's Modified Eagle Medium, DMEMDevice
Study preparation (placebo comparator) of 0.8 mL will be injected intradermally at Baseline and Week 6.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Systemic safety measures will be assessed by measuring vital signs, adverse experiences, laboratory tests (hematology, clinical chemistry and urinalysis)and immunological response (anti-drug antibodies)Time frame: Clinically significant change from screening visit to Week 12
- Non-vellus hair countsTime frame: Change from Baseline to week 12 in treatment areas
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Medical City
Pasig, Manila, Philippines
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.